Key result
Medical management of chronic stable angina with beta blockers, calcium channel antagonists, nitrates, aspirin, and statins is recommended to relieve symptoms and prevent cardiovascular events.
Medical management of chronic stable angina focuses on symptom relief with beta blockers, calcium channel antagonists, and nitrates, alongside cardiovascular event prevention using aspirin and statins.
Supports medical therapy for stable angina symptom relief and prevention; leaves open optimal integration with modern revascularization.
Stable angina pectoris is characterised by typical exertional chest pain that is relieved by rest or nitrates. Risk stratification of patients is important to define prognosis, to guide medical management and to select patients suitable for revascularisation. Medical treatment aims to relieve angina and prevent cardiovascular events. Beta blockers and calcium channel antagonists are first-line options for treatment. Short-acting nitrates can be used for symptom relief. Low-dose aspirin and statins are prescribed to prevent cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Wee et al. (2015) conducted a review in Chronic stable angina. Medical management (beta blockers, calcium channel antagonists, nitrates, aspirin, statins) was evaluated. Medical management of chronic stable angina with beta blockers, calcium channel antagonists, nitrates, aspirin, and statins is recommended to relieve symptoms and prevent cardiovascular events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: